Pregabalin

Article Details

Citation

Copy to clipboard

Cross AL, Sherman Al

Pregabalin

.

PubMed ID

29261857 [ View in PubMed

]

Abstract

Pregabalin is approved by the United States Food and Drug Administration (FDA) for the treatment of neuropathic pain associated with diabetic peripheral neuropathy, spinal cord injury and postherpetic neuralgia. Pregabalin is FDA-approved for the treatment of fibromyalgia. Pregabalin is also FDA approved as an adjunctive therapy for partial onset seizures in adults with epilepsy. Off-label uses include generalized anxiety disorder, social anxiety disorder, bipolar disorder, insomnia and chronic pain conditions not otherwise approved by the FDA. There is significant disagreement regarding the effectiveness of pregabalin for the psychiatric disorders listed above.[1][2][3][4]

DrugBank Data that Cites this Article

Drugs

Pregabalin